Covered recipient · General Payments record
JANICE A CARR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$4,986.50
- Reported across 299 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,270.15 | 67 |
| Education | $116.02 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $213.18 | 9 |
| Daiichi Sankyo Inc. | $208.32 | 11 |
| GENZYME CORPORATION | $110.20 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $107.72 | 6 |
| Merck Sharp & Dohme Corporation | $76.66 | 4 |
| GlaxoSmithKline, LLC. | $73.94 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $62.46 | 3 |
| Pharmacosmos Therapeutics Inc. | $57.74 | 3 |
| Incyte Corporation | $49.12 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $47.54 | 2 |
| Myriad Genetic Laboratories, Inc. | $42.87 | 2 |
| EISAI INC. | $34.53 | 2 |
| Gilead Sciences, Inc. | $31.63 | 2 |
| E.R. Squibb & Sons, L.L.C. | $27.70 | 2 |
| TAIHO ONCOLOGY, INC. | $21.70 | 1 |
| Genentech USA, Inc. | $19.83 | 1 |
| SOBI, INC | $18.89 | 1 |
| Kyowa Kirin, Inc. | $18.29 | 1 |
| Tempus AI, Inc | $18.16 | 1 |
| Karyopharm Therapeutics Inc. | $17.85 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $16.53 | 1 |
| Acrotech Biopharma Inc. | $16.34 | 1 |
| Astellas Pharma US Inc | $16.30 | 1 |
| EMD Serono, Inc. | $16.13 | 1 |
| Coherus Biosciences Inc. | $15.57 | 1 |
| Octapharma USA, Inc. | $15.13 | 1 |
| Deciphera Pharmaceuticals Inc. | $14.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (69)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.